home / stock / clnn / clnn quote
Last: | $0.372 |
---|---|
Change Percent: | -2.62% |
Open: | $0.3797 |
Close: | $0.372 |
High: | $0.3896 |
Low: | $0.365 |
Volume: | 267,858 |
Last Trade Date Time: | 05/20/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.372 | $0.3797 | $0.372 | $0.3896 | $0.365 | 267,858 | 05-20-2024 |
$0.37 | $0.392 | $0.37 | $0.392 | $0.37 | 319,221 | 05-17-2024 |
$0.3856 | $0.394 | $0.3856 | $0.3949 | $0.3746 | 194,325 | 05-16-2024 |
$0.3826 | $0.39 | $0.3826 | $0.395 | $0.375 | 214,863 | 05-15-2024 |
$0.3841 | $0.384 | $0.3841 | $0.3999 | $0.3664 | 367,901 | 05-14-2024 |
$0.3908 | $0.3917 | $0.3908 | $0.3999 | $0.361 | 439,843 | 05-13-2024 |
$0.3865 | $0.4063 | $0.3865 | $0.427 | $0.38 | 578,708 | 05-10-2024 |
$0.387 | $0.395 | $0.387 | $0.4273 | $0.385 | 294,024 | 05-09-2024 |
$0.3899 | $0.389 | $0.3899 | $0.4 | $0.3666 | 427,332 | 05-08-2024 |
$0.3914 | $0.43 | $0.3914 | $0.43 | $0.384 | 313,159 | 05-07-2024 |
$0.4236 | $0.42 | $0.4236 | $0.433 | $0.4022 | 260,117 | 05-06-2024 |
$0.4349 | $0.434 | $0.4349 | $0.4397 | $0.42 | 310,225 | 05-03-2024 |
$0.4367 | $0.41 | $0.4367 | $0.4367 | $0.4064 | 429,765 | 05-02-2024 |
$0.437 | $0.4168 | $0.437 | $0.4389 | $0.38 | 959,038 | 05-01-2024 |
$0.4318 | $0.353 | $0.4318 | $0.439 | $0.353 | 2,369,477 | 04-30-2024 |
$0.3517 | $0.3439 | $0.3517 | $0.35445 | $0.34 | 148,177 | 04-29-2024 |
$0.3399 | $0.3465 | $0.3399 | $0.35 | $0.3301 | 120,352 | 04-26-2024 |
$0.3465 | $0.335 | $0.3465 | $0.355 | $0.33 | 382,088 | 04-25-2024 |
$0.337 | $0.3384 | $0.337 | $0.34 | $0.325 | 303,214 | 04-24-2024 |
$0.3351 | $0.3374 | $0.3351 | $0.3475 | $0.3263 | 308,950 | 04-23-2024 |
News, Short Squeeze, Breakout and More Instantly...
Clene Inc. Company Name:
CLNN Stock Symbol:
NASDAQ Market:
SALT LAKE CITY, May 14, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ:CLNN) (along with its subsidiaries, "Clene") and its wholly owned subsidiary...
Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, today...
SALT LAKE CITY, May 14, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neurona...